Newly diagnosed prostate cancer. Staging exam. Pathology dated 5/13/2016: Prostatic adenocarcinoma 3+3 R2, 3+3 L3-L5, PELVIS:PROSTATE:Prostate Size: 4.6 x 5.1 x 5.2 cmPeripheral Zone: The peripheral zone demonstrates diffusely heterogeneously mildly to moderately T2 weighted hypointense signal intensity without associated decreased ADC signal intensity, low suspicion. There are several scattered more focally T2 weighted hypointense foci throughout the peripheral zone including a left apex lesion measuring 8 x 6 mm (series 401/9).Central Gland: Mild changes of BPH. Note is made of a cystic lesion just cranial to the base of the prostate, likely a mullerian duct remnant cyst. In the right anterior apex there is a 1.6 x 1.3 cm well-defined heterogeneously hypointense lesion (series 401/12) demonstrating arterial enhancement which may represent a BPH nodule but is indeterminate.Seminal Vesicles: No evidence of seminal vesicle tumor involvement.Extracapsular Extension: No evidence of extracapsular extension of tumor.BLADDER: Distended urinary bladder with trabecular thickening and a dorsal diverticulum.LYMPH NODES: No significant abnormality noted.BONES, SOFT TISSUES: No significant abnormality noted.OTHER: No significant abnormality noted.
1.Heterogeneous peripheral zone severely limits evaluation and may be due to prostatitis with mildly suspicious index lesions described above. 2.Right apical central gland lesion most likely represent a BPH nodule.